Cascade Biocatalysts is a biotechnology company specializing in the development of advanced enzyme immobilization technology for use across multiple industries including food, chemicals, waste management, and pharmaceuticals. The company's core innovation, branded as Body Armor for Enzymes, involves stabilizing enzymes on silica beads to dramatically extend their operational lifespan, broaden their tolerance to temperature, pH, and solvents, and enable reusability within existing industrial processes. Their cell-free biocatalysts have demonstrated up to 100x improved performance compared to conventional enzyme solutions, with a reported 100% success rate across 17 different enzymes tested to date. Cascade Biocatalysts' mission is to transform chemical manufacturing by leveraging biology to replace traditional, energy-intensive chemical processes. By enabling cascades of enzymes to synthesize virtually any molecule, the company aims to reduce reliance on fossil-fuel-derived reagents and harsh chemical processes, contributing directly to greener, more sustainable industrial manufacturing. Their platform supports a circular economy approach through reusable biocatalysts that lower costs and reduce waste. What sets Cascade Biocatalysts apart is their proprietary silica-based immobilization platform, which makes highly sensitive enzymes resilient enough for demanding industrial environments. Current offerings include immobilized lipases and immobilized carbonic anhydrase, with the ability to customize resin solutions for client-specific enzymes. The company positions itself as a drop-in solution provider, allowing manufacturers to integrate more sustainable biocatalytic processes without overhauling existing infrastructure.